Astrazeneca’s Dapagliflozin gets DCGI nod for treatment of heart failure
Dapagliflozin (Forxiga) is an SGLT-2 inhibitor that can reduce the risk of cardiovascular death and hospitalisation for heart…
Recover your password.
A password will be e-mailed to you.